With access to broad donor pools at over 200 IRB-approved collection sites to source tissue and primary cells from healthy, normal or disease state donors as well as access to all commercially available animal models, BioIVT can advance your Cell Therapy/Regenerative Medicine research.
Naive and patients on treatments
Access to repeat donors
Purified, CD-marker-expressing cell populations
Cell lysates for endogenous growth factors
Enriched cell products (LEUKOMAX™ units) for pilot studies